Lung Cancer in Belgium

J Thorac Oncol. 2021 Oct;16(10):1610-1621. doi: 10.1016/j.jtho.2021.07.022.

¹ Division of Pneumology, CHU UCL Namur (Godinne Site), Université catholique de Louvain (UCLouvain), Yvoir, Belgium; Pole of Pneumology, ENT, and Dermatology (PNEU), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Brussels, Belgium. Electronic address: sebahat.ocak@uclouvain.be.
² Division of Pneumology, Onze-Lieve-Vrouw Ziekenhuis (OLV) Aalst and Faculty of Medicine and Life Sciences, Ghent University, Ghent, Belgium.
³ Thoracic Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
⁴ Division of Pneumology, AZ Delta Roeselare, Roeselare, Belgium.
⁵ Division of Cardiovascular and Thoracic Surgery, CHU Liège, Liège, Belgium.
⁶ Division of Thoracic Oncology, UZ Antwerpen, Edegem, Belgium.
⁷ Department of Radiation Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
⁸ Division of Respiratory Oncology/Pneumology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
⁹ Cliniques Universitaires St-Luc, UCLouvain, Brussels, Belgium; Pole of Pneumology, ENT, and Dermatology (PNEU), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Brussels, Belgium.
¹⁰ Division of Pneumology, UZ Gent, Ghent, Belgium.
¹¹ Belgian Cancer Registry (BCR), Brussels, Belgium.
¹² Belgian Health Care Knowledge Centre (KCE), Brussels, Belgium.
¹³ Department of Pathology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.

No abstract available

Publication types